المؤلفون: Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oho

المصدر: Journal of Obesity & Metabolic Syndrome; Dec2023, Vol. 32 Issue 4, p289-302, 14p

مصطلحات موضوعية: FATTY liver, NON-alcoholic fatty liver disease, LIVER diseases, QUALITY control, GLUCAGON-like peptide-1 receptor, HEPATIC fibrosis

الشركة/الكيان: UNITED States. Food & Drug Administration

المؤلفون: Young-Gyun Seo¹ yg035@daum.net

المصدر: Journal of Obesity & Metabolic Syndrome. Mar2021, Vol. 30 Issue 1, p12-19. 8p.

مصطلحات موضوعية: *DRUG side effects, *GLUCAGON-like peptide-1 receptor, *LIRAGLUTIDE, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes

المؤلفون: Chan-Hee Jung¹, Ji-Oh Mok¹ hanna@schmc.ac.kr

المصدر: Journal of Obesity & Metabolic Syndrome. 2019, Vol. 28 Issue 1, p18-29. 12p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *SODIUM-glucose cotransporters, *GLUCAGON-like peptide-1 agonists, *FATTY liver, *HYPOGLYCEMIC agents, *TYPE 2 diabetes

المؤلفون: Young-Gyun Seo

المصدر: Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome, Vol 30, Iss 1, Pp 12-19 (2021)

مصطلحات موضوعية: medicine.medical_specialty, Side effect, Endocrinology, Diabetes and Metabolism, Adverse drug reaction, Review, Drug side effect, lcsh:Diseases of the endocrine glands. Clinical endocrinology, Diabetes mellitus, Internal medicine, Medicine, Obesity, Adverse effect, Glucagon-like peptide 1 receptor, lcsh:RC648-665, business.industry, Liraglutide, Type 2 Diabetes Mellitus, medicine.disease, Glucagon-like peptide-1 receptor, business, Body mass index, Adverse drug event, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d048b0683fd27927ec9b0432ae9cd4cTest
http://europepmc.org/articles/PMC8017323Test

المؤلفون: Ji-Oh Mok, Chan-Hee Jung

المصدر: Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome, Vol 28, Iss 1, Pp 18-29 (2019)

مصطلحات موضوعية: lcsh:RC648-665, business.industry, Endocrinology, Diabetes and Metabolism, Fatty liver, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Review, Pharmacology, medicine.disease, Glucagon-like peptide-1, lcsh:Diseases of the endocrine glands. Clinical endocrinology, digestive system, digestive system diseases, Sodium-glucose cotransporter 2 inhibitor, Pharmacotherapy, Sodium/Glucose Cotransporter 2, Type 2 diabetes mellitus, Medicine, Glucagon-like peptide-1 receptor agonist, Steatohepatitis, Receptor, business, Glucagon-like peptide 1 receptor, Non-alcoholic fatty liver disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e80ad7c1b618bd1869451b20755637dTest
http://europepmc.org/articles/PMC6484938Test